Search - tctmd.com

Displaying 1 - 20 of 212

Sort: Relevancy | Date

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Daily News

Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE

Michael O'Riordan

September 26, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

Advertisement

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Experience Matters as Ross Procedure Gains Popularity in North America

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Frail Patients Stand to Gain Most From Cardiac Rehab

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

Prophylactic Pacemakers After TAVI Provide Little Benefit: PROMOTE

CVD Still the Leading Cause of Death and Disease Globally

FDA Expands Evolut Indications to Include Redo TAVI

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content